SCHEMBL21971408

SCHEMBL21971408

Cc1cccc(N(C)C)c1C1N(C)c2ccccc2N1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 4/20 0.33
▸ GAA P10253 3/20 0.33
▸ HTT P42858 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ NSD2 O96028 1/20 0.31
▸ EGFR P00533 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ KCNN4 O15554 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21971004 0.90 PDGFRB (0.53) PDGFRBKDM4ELMNAMAPTGAA
SCHEMBL21971000 0.80 LMNA (0.49) PDGFRBKDM4ELMNAMAPTCA2
SCHEMBL21972255 0.76 LMNA (0.42) PDGFRBKDM4ELMNAGAAHTT
SCHEMBL20508364 0.75 PDGFRB (0.53) PDGFRBKDM4ELMNAMAPTGAA
SCHEMBL20739438 0.75 PDGFRB (0.57) PDGFRBKDM4ELMNAMAPTGAA
SCHEMBL21971407 0.73 KDM4E (0.40) PDGFRBKDM4ELMNAMAPTGAA
SCHEMBL21972245 0.73 LMNA (0.53) KDM4ELMNAMAPTHTTHTR2A
SCHEMBL21971402 0.73 PDGFRB (0.47) PDGFRBKDM4ELMNAMAPTGAA
SCHEMBL21972250 0.72 PDGFRB (0.46) PDGFRBKDM4ELMNAMAPTHTT
SCHEMBL15320331 0.69 KDM4E (0.45) PDGFRBKDM4ELMNAHTTEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 PDGFRB 2517/4885KDM4E 4526/4885LMNA 4733/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 PDGFRB 2499/4885KDM4E 4760/4885LMNA 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback